Soltero R G, Hansbrough J F
Department of Surgery, University of California San Diego Medical Center, 92103, USA.
J Trauma. 1999 Feb;46(2):286-91. doi: 10.1097/00005373-199902000-00015.
Diaspirin cross-linked hemoglobin (DCLHb) is a vasoactive hemoglobin-based oxygen carrier or "blood substitute" that has been shown to improve base deficit in several experimental studies of hemorrhagic shock. Our objective was to determine if the addition of DCLHb to the resuscitation regimen would improve hemodynamic parameters, metabolic acidosis, and survival in our rat burn shock model compared with currently used resuscitation therapy.
This was a randomized, controlled, experimental rat study. Male Wistar rats, weighing 200 to 250 g, were surgically prepared for an acute study. After placement of indwelling catheters, baseline hemodynamic values (mean arterial pressure, cardiac output, systemic vascular resistance, stroke volume, and base excess) were obtained. Thirty-two rats were used in the study, and they were either subjected to a 30% scald burn (experimental group) or sham burned (control group). The experimental animals were immediately intravenously resuscitated and followed for 6 hours. The resuscitation was based on the Parkland formula (4 mL/kg for each 1% of total body surface area [TBSA] burn), with 50% of the calculated fluid amount to be administered at a constant rate during the first 8 hours after burn. The animals were resuscitated for 6 hours and received between 9.00 and 11.25 mL of fluid depending on weight. The experimental animals were randomly assigned to one of three treatment groups: group I, lactated Ringer's solution; group II, lactated Ringer's solution-human serum albumin; group III, lactated Ringer's solution-DCLHb. Group I (n = 8) received 4 mL/kg lactated Ringer's solution for each 1% of TBSA burn. Group II (n = 8) received 2 mL/kg lactated Ringer's solution and 2 mL/kg human serum albumin for each 1% of TBSA burn. Group III (n = 8) received 2 mL/kg lactated Ringer's solution and 2 mL/kg DCLHb for each 1% of TBSA burn. The sham group (n = 8) was not burned and was not resuscitated. Animals that survived up to 6 six hours were killed.
We found that mean arterial pressure, cardiac output, stroke volume, and base excess were all improved in the DCLHb-lactated Ringer's solution-treated animals compared with the other experimental treatment groups. The 6-hour mortality rates were zero of eight (lactated Ringer's solution-DCLHb group), zero of eight (sham group), three of eight (lactated Ringer's solution-human serum albumin group), and six of eight (lactated Ringer's solution only group).
Early resuscitation with DCLHb is superior to non-oxygen-carrying resuscitative fluids in improving hemodynamics and survival in this model of burn shock. DCLHb might improve general tissue perfusion in the acute postburn period, and it could be useful in the early management of patients with severe burns.
双阿司匹林交联血红蛋白(DCLHb)是一种具有血管活性的基于血红蛋白的氧载体或“血液替代品”,在多项失血性休克实验研究中已显示可改善碱缺失。我们的目的是确定与目前使用的复苏治疗相比,在复苏方案中添加DCLHb是否能改善我们大鼠烧伤休克模型的血流动力学参数、代谢性酸中毒和生存率。
这是一项随机、对照的实验性大鼠研究。体重200至250克的雄性Wistar大鼠接受手术准备以进行急性研究。放置留置导管后,获取基线血流动力学值(平均动脉压、心输出量、全身血管阻力、每搏量和碱剩余)。32只大鼠用于该研究,它们要么遭受30%的烫伤(实验组),要么进行假烫伤(对照组)。实验动物立即接受静脉复苏并随访6小时。复苏基于Parkland公式(每1%体表面积[TBSA]烧伤给予4 mL/kg),计算出的液体量的50%在烧伤后的前8小时以恒定速率给予。动物复苏6小时,根据体重接受9.00至11.25 mL的液体。实验动物被随机分配到三个治疗组之一:第一组,乳酸林格液;第二组,乳酸林格液-人血清白蛋白;第三组,乳酸林格液-DCLHb。第一组(n = 8)每1% TBSA烧伤接受4 mL/kg乳酸林格液。第二组(n = 8)每1% TBSA烧伤接受2 mL/kg乳酸林格液和2 mL/kg人血清白蛋白。第三组(n = 8)每1% TBSA烧伤接受2 mL/kg乳酸林格液和2 mL/kg DCLHb。假手术组(n = 8)未烧伤且未接受复苏。存活至6小时的动物被处死。
我们发现,与其他实验治疗组相比,DCLHb-乳酸林格液治疗的动物的平均动脉压、心输出量、每搏量和碱剩余均得到改善。6小时死亡率在8只中为0(乳酸林格液-DCLHb组),8只中为0(假手术组),8只中为3(乳酸林格液-人血清白蛋白组),8只中为6(仅乳酸林格液组)。
在该烧伤休克模型中,早期使用DCLHb复苏在改善血流动力学和生存率方面优于非携氧复苏液。DCLHb可能在烧伤后急性期改善全身组织灌注,并且在严重烧伤患者的早期管理中可能有用。